Project Grant R44OD023029

Award Date 9/15/17
Completion Date 7/31/25
Dollars Obligated $2.9M
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Houston, TX 77036, USA
Similar Awards
This $769,749 Project Grant from the National Institutes of Health's National Institute of General Medical Sciences will support the development of Fluorescence Enhanced Photothermal Infrared Spectroscopy (FE-PTIR) technology by Photothermal Spectroscopy Corp. The FE-PTIR technique aims to provide simultaneous fluorescence microscopy and sub-micron infrared spectroscopy to map the distribution of fluorescently labeled biomolecules within cells and tissues while also analyzing their chemical...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $399,491 to Northridge Tri-Modality Imaging Inc. to upgrade their gantry-based combined X-ray CT and fluorescent tomography (FLT) system. The key objectives are to add bioluminescence tomography (BLT) capability and enhance the FLT sensitivity and image acquisition speed by integrating an intensified-CCD (ICCD) camera. This upgraded multi-modality...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $249,000 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to Case Western Reserve University. The grant will fund the development of a high-throughput photoacoustic histology platform to enable real-time intraoperative pathological diagnosis. Key objectives include creating an ultrafast reflection-mode ultraviolet...
This Cooperative Agreement award from the Department of Health and Human Services' Advanced Research Projects Agency for Health (ARPA-H) (CFDA 93.384) provides $4,116,367 to Northeastern University and sub-awardees the University of Washington and Johns Hopkins University to develop a "Fully Integrated Acousto-Optical Electronic-Photonic System for Real-Time In Vivo 3D Photoacoustic Imaging." The project aims to create a miniature, high-resolution photoacoustic imaging platform that...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) aims to develop and commercialize Video Rate Photothermal Infrared (VR-PTIR) imaging and spectroscopy. The $1,935,256 award to Photothermal Spectroscopy Corp., a minority-owned for-profit company in Santa Barbara, California, will provide 10-30x better spatial resolution than conventional infrared (IR) spectroscopy and operate up to...
This $272,835 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program, aims to develop a new Probe-Based Light Sheet Microscopy (PLSM) device and evaluate its clinical utility for in vivo imaging of the anal mucosa during cancer screening. The University of Arizona, as the prime awardee, will collaborate with researchers from Memorial...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will fund the development and validation of a novel optical scanning probe microscope (SPM) system for high-resolution, high-sensitivity chemical imaging in biomedical applications. The $295,308 award will support Actoprobe LLC in Albuquerque, NM to create a SPM probe...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286) will fund the development of a novel molecular imaging technology that combines positron emission tomography (PET) and ultrasound (US) imaging. The key products to be delivered through this $1,541,316 award include: A compact PET device with a robotic arm to enable...
The National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), awarded a $400,000 Project Grant to O2M Technologies LLC to improve the image acquisition speed of their Single Point Imaging (SPI) oxygen mapping technology. SPI is a subset of the company's Pulse Electron Paramagnetic Resonance Imaging (PEPRI) method, which can generate high-resolution 3D partial oxygen pressure (pO2) maps in live tissues and tumors. The goal of this project is to...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $567,340 to develop and validate a wide-field fluorescence lifetime (FLT) imaging system for intraoperative cancer detection during sarcoma surgeries. The Massachusetts Eye and Ear Infirmary, a non-profit hospital and research center, will lead the 4-year...

INTEGRATED PHOTOACOUSTIC AND FLUORESCENCE IMAGING SYSTEM FOR ANATOMICAL, FUNCTIONAL, AND MOLECULAR CHARACTERIZATION OF MURINE MODELS - SUMMARY PHOTOSOUND TECHNOLOGIES, INC. PROPOSES TO DEVELOP A NOVEL IMAGING MODALITY FOR CHARACTERIZATION AND PRECLINICAL RESEARCH OF SMALL ANIMAL MODELS. THE TECHNOLOGY WILL BE CAPABLE OF THREE-DIMENSIONAL FUNCTIONAL AND MOLECULAR IMAGING OF FLUORESCENT LABELS AND REPORTER GENES MAPPED WITH HIGH FIDELITY OVER ROBUST ANATOMICAL STRUCTURES, SUCH AS SKIN, CENTRAL AND PERIPHERAL VASCULATURE, AND INTERNAL ORGANS. THE PHASE II COMMERCIAL INSTRUMENT IS DESIGNED TO PERFORM HIGH-THROUGHPUT WHOLE BODY IMAGING OF RODENT MODELS. IT COULD BE USED IN BROAD SPECTRUM OF PRECLINICAL RESEARCH APPLICATIONS INCLUDING CANCER, TOXICOLOGY, TISSUE ENGINEERING AND REGENERATION, CARDIOVASCULAR AND DEVELOPMENTAL BIOLOGY. IN ADDITION TO QUALITATIVELY SUPERIOR PERFORMANCE CHARACTERISTICS, THE PROPOSED MULTIMODALITY IMAGING PLATFORM WILL SIGNIFICANTLY REDUCE SPACE AND FUNDS REQUIRED TO HOUSE AND OPERATE A WHOLE-BODY IMAGING PLATFORM AT AN ANIMAL RESEARCH FACILITY. OPTICAL IN VIVO IMAGING METHODS (FLUORESCENCE AND BIOLUMINESCENCE) FOUND GREAT POPULARITY AMONG RESEARCHERS AS AFFORDABLE, CONVENIENT, AND VERY SENSITIVE MOLECULAR IMAGING TOOLS FOR PRECLINICAL STUDIES AND DEVELOPMENT OF ANIMAL MODELS. HOWEVER, THEIR STAND-ALONE APPLICATION IS IMPEDED BY POOR SPATIAL RESOLUTION AND LIMITATIONS IMPOSED BY TWO-DIMENSIONALITY OF THE IMAGES. A FAST AND HIGH-RESOLUTION IN VIVO 3D IMAGING METHOD, WHICH COULD BE EASILY INTEGRATED WITH OPTICAL IMAGING IN A SINGLE INSTRUMENT, WOULD HAVE A GREAT IMPACT ON THE ENTIRE FIELD OF SMALL ANIMAL RESEARCH. PHOTOACOUSTIC TOMOGRAPHY IS AN EMERGING WHOLE BODY 3D IMAGING MODALITY CAPABLE OF 200-500 MM RESOLUTION. IT CAN ALSO USE THE SAME COMPONENTS FOR EXCITATION OF FLUORESCENCE AND GENERATION OF PHOTOACOUSTIC EFFECT. HOWEVER, ITS IN VIVO APPLICATION FOR DETECTION OF FLUOROPHORES IS IMPEDED BY STRONG BACKGROUND GENERATED BY NATIVE BLOOD. ALSO, THERE ARE NO COMMERCIAL OR RESEARCH PHOTOACOUSTIC WHOLE- BODY IMAGING INSTRUMENT THAT COULD WORK WITH HIGH-THROUGHPUT IMAGING PROCEDURES (

Posted 8/9/22, 12:00 AM